Blog Read the latest perspectives from our team of subject matter experts and others AI in Clinical TrialsAt Fierce JPM Week 2026, Ariel Katz, CEO and Co-founder of H1, sat down with Paul Bridges, PhD, President of Parexel’s Consulting organization, for a fireside chat that cut… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Sorry! No posts found for the applied filter.
